The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc, as per the Irish Takeover Panel regulations. The form 8.3 submission reveals Vanguard controls 771,667 ordinary shares, representing 4.47% ownership.

The disclosure is made under Rule 8.3 of the Irish Takeover Panel Act 1997, and it pertains to relevant securities representing 1% or more. The data reflects the holdings as of August 21, 2025.

There have been no cash-settled or stock-settled derivative positions reported. Additionally, no indemnity or other arrangements influencing dealings were declared. The disclosure indicates no supplemental form is required, as further agreements or understandings related to the securities are absent.